At last, our in vivo experimental data confirmed the downregulation of CENPA/Myc/Bcl2 by NRMT silencing, which possibly could be the mechanism responsible for the enhanced chemosensitivity of retinoblastoma cells. This evidence concerns the gene BCL2 and retinoblastoma.